Cell News and Research

RSS

INTEGRA Biosciences announces the appointment of a new board member

INTEGRA Biosciences is excited to welcome Line Stigen Raquet as a non-executive board member.

From INTEGRA Biosciences 17 Jun 2024

Finnish researchers discover mechanism behind breast cancer cell reactivation

Treatment outcomes for breast cancer have become better over the years, but proportion of breast cancers still recur even after long periods without signs of cancer remaining dormant in the body.

17 Jun 2024

CSHL researchers reveal MED12 as key player in basal-like pancreatic cancer

Things aren't always as they seem. Take pancreatic cancer, for example. In up to one in 10 cases, researchers have documented a peculiar characteristic.

17 Jun 2024

At-home antibody tests could drive higher COVID-19 booster rates, new research finds

The feasibility and benefits of lateral flow assay (LFA)-based antibody tests for detecting inadequate COVID-19 immunity.

17 Jun 2024

Understanding salivary gland microenvironment to advance Sjögren's disease treatment

TLS are accumulations of lymphoid cells that share similar cellular compartments, organization, and function as secondary lymphoid organs. Importantly, the presence of these structures in inflamed salivary glands associated with active disease, increased autoantibody production, and malignancy risk.

16 Jun 2024

Paternal and maternal transplants boost infant gut health after cesarean delivery

Researchers explore the paternal role in infant gut seeding and the impact of induced seeding by maternal fecal microbiota transplant.

16 Jun 2024

Promising gene editing therapy shows hope in sickle cell disease cure

Researchers have presented the latest findings from a clinical trial aimed at discovering a cure for sickle cell disease, a painful genetic blood disorder with limited treatment options.

14 Jun 2024

St. Jude researchers uncover NLRC5's role in immune response and cell death

The innate immune system is responsible for protecting the human body from threats that could cause disease or infection.

14 Jun 2024

Innovative 3D cell culturing method offers new insights into cancer cell mechanics

Developing chemotherapy drugs against breast cancer is costly, slow, and often inefficient, with more than 95% of screened drug candidates failing in patient trials.

14 Jun 2024

Sphere Fluidics awarded gold accreditation by investors in people

Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced that it has received the ‘We invest in people’ Gold accreditation, a prestigious award presented by Investors in People (IIP). This accolade is in recognition of the Company's commitment to excellence in people management and continuous improvement in workplace practices.

From Fluidic Sciences and Sphere Bio 14 Jun 2024

Younger gut microbiota age reduces cardiovascular disease risk in older adults

Researchers identified gut microbiota signatures and developed a microbial age metric, demonstrating that a younger microbial age may reduce cardiovascular disease (CVD) risk in metabolically unhealthy older adults.

14 Jun 2024

Case study sheds light on CAR-T therapy-related secondary cancers

A new detailed analysis of a patient's second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended to offer helpful guidance for oncologists and pathologists about the clinical presentation and pathologic features involved in a CAR-T related second cancer.

13 Jun 2024

Mutated TREX1 gene linked to catastrophic DNA damage and deadly rare disease

TREX1 is a gene that is supposed to direct the maintenance of the entire body's DNA, but new research shows that when people are born with mutated TREX1, it causes catastrophic damage to the DNA over time, resulting in a deadly rare disease called retinal vasculopathy with cerebral leukoencephalopathy (RVCL).

13 Jun 2024